由 Sarah Stapleton | 8月 12, 2024
On August 9, 2024, Shanghai ChemPartner Co., Ltd (ChemPartner) and the Hong Kong Polytechnic University (PolyU) marked the signing of a Memorandum of Understanding (MOU). The MOU was signed by Professor Larry Ming Cheung Chow, Head of the Department of Applied Biology...
由 Corah Whipple | 12月 22, 2023
Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs ChemPartner, a global leader in drug discovery and development services, today announced the launch of its long-awaited Biology Database....
由 Corah Whipple | 6月 21, 2023
ChemPartner announced today the appointment of Yinfei Yin, Ph.D. as vice president of and head of the biology and pharmacology department at Shanghai ChemPartner. Dr. Yin brings a wealth of experience and expertise to his new role, having established himself as a...
由 Sarah Stapleton | 2月 6, 2023
ChemPartner received a 2023 CDMO Leadership Award in Every Core Category There are six core categories in the CDMO Leadership Awards: Capabilities, Compatibility, Expertise, Quality, Reliability and Service. Winners in these categories are judged by their...
由 Sarah Stapleton | 3月 23, 2021
Shanghai, China (March 23, 2020) – Shanghai ChemPartner announced today the appointment of Cheng-Chi Chao, Ph.D. as Vice President and Head of Immunotherapy and Inflammation. Dr. Chao has over 20 years of experience in drug development and extensive expertise in the...
由 Sarah Stapleton | 6月 11, 2020
Shanghai, China (June 9, 2020) – Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing. “ChemPartner has...
由 Sarah Stapleton | 5月 12, 2020
Shanghai, China (May 12, 2020) – Shanghai ChemPartner announced they have entered into a non-exclusive agreement with the Mount Sinai Health System (Mount Sinai) to assist in a trial production run of a component of the Mount Sinai COVID-19 serological assay that...
由 Sarah Stapleton | 4月 17, 2020
SAN FRANCISCO, Calif. and SHANGHAI, China. (April 15, 2020) – In a new collaboration, Chempartner Corporation (ChemPartner), the US arm of a leading pre-clinical contract research and development organization (CRO), is partnering with scientists at Gladstone...
由 Sarah Stapleton | 4月 2, 2020
Shanghai, China (March 17, 2020) – Shanghai ChemPartner announced the opening of a new, state-of-the-art, 24,000 m2 laboratory facility in the Zhangjiang Hi-Tech Park in Shanghai, China. The building, operating as ChemPartner’s new Global Operation Center, houses...
由 Sarah Stapleton | 12月 18, 2019
Shanghai, China (December 17, 2019) – Shanghai ChemPartner announced the appointment of Jie Jack Li, Ph.D. as a Vice President of Discovery Chemistry at the Company headquarters in Shanghai, China. Dr. Li is an established chemist with over 20 years of experience in...
